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Aims: Very elderly subjects represent the fastest growing population in the world. Most
of the recent studies on intracerebral hemorrhage (ICH) have been carried out on younger
patients and/or preferably using novel radiological techniques. We investigated the preva-
lence, risk factors, and histopathological characteristics of the ICH in the oldest old. Mate-
rials and methods:The brains of 300 autopsied individuals (248 females, 52 males, mean
age at death 92.4± 3.7 years)were investigated as part of the prospective population-based
Vantaa 85+ study. After macroscopic investigation, the presence and extent of micro-
scopic brain hemorrhages (MH) were analyzed by counting the number of iron containing
macrophages (siderophages) by Prussian blue staining. Deposits with >5 siderophages
were deﬁned as MH+, forming a subgroup of MH. Genotyping of apolipoprotein E (APOE )
and the analysis of microscopic (MI) or larger infarctions and cerebral amyloid angiopa-
thy (CAA) were performed using standardized methods. Regression analysis was used
to predict the presence of ICH, with and without co-localized CAA, and was adjusted for
age at death and gender. Results:The prevalence of macroscopic ICH was 2.3% in total;
consisting of 1% large lobar hemorrhage (LH), 1% deep hemorrhage (DH), and 0.3% of
subarachnoid hemorrhage (SAH). 62% had MH and 15.3% MH+. All MH+ lesions were
found to be >2mm wide. 55.9% of subjects with MH and 81.2% of those with MH+
showedMH/MH+ and CAA in the same brain region (MHCAA andMH+CAA, respectively).
MH was associated with none of the neuropathological or clinical conditions, nor with the
APOE carrier status. The subjects with MH+, MHCAA or MH+CAA carried the APOE ε4
allele more frequently than controls (OR 3.681, 3.291, 7.522, respectively). Siderophages
in MH+CAA co-localized with CAA and with two-thirds of the MI in the tissue sections.
Conclusion: Macroscopic ICH was rare in the very elderly. MH was frequent and clini-
cally insigniﬁcant. MH+ was rare but closely related with the APOE ε4 genotype and the
presence of severe CAA and infarction.
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INTRODUCTION
Lobar hemorrhage (LH) and deep hemorrhage in the basal
ganglia–thalamus region (DH) are life-threatening end stage com-
plications of cerebral amyloid angiopathy (CAA) and hyperten-
sion, respectively. These lesions are mostly diagnosed in subjects
aged 60–70 years. Cerebral microhemorrhages, “focal deposits of
red blood cells and hemosiderin” (Fazekas et al., 1999), can be
detected using the gradient echo T2∗-weighted MRI scan. The
microscopic hemorrhagic lesions detected in MRI (microbleeds)
are suggested to be related to CAA (Vernooij et al., 2008; Dierksen
et al., 2010). This is supported by (1) the increasing prevalence of
microbleeds and CAA with age (Vinters and Gilbert, 1983; Ver-
nooij et al., 2008; Poels et al., 2010), and (2) lobar microbleeds
being strictly associated with the possession of the apolipoprotein
E (APOE) ε4 allele (Vernooij et al., 2008) or APOE ε4/4 genotype
(Sveinbjornsdottir et al., 2008), similar to CAA (Yamada, 2002).
The histopathological characteristics of intracerebral hemor-
rhage (ICH) include tissue edema, neuronal changes, activation
of the microglia, inﬁltration of the hematogenous macrophages,
and phagocytosis of the erythrocytes by phagocytic cells (Koeppen
et al., 1995; Qureshi et al., 2001; Zhao et al., 2009). Sponta-
neous bleeding in the brain can also result from hemorrhagic
transformation of an ischemic brain lesion (Balami et al., 2011).
Histopathological studies of microscopic hemorrhagic lesions in
the cerebral cortex and/or subcortical regions are scarce. In a sub-
set (≥95 years) of the Vantaa population they were more frequent
in the subjects with CAA than in those without (Tanskanen et al.,
2005). A recent histopathological study reported a microbleed in
the subcortical white matter of occipital lobe in 1 in 12 elderly
subjects (Fisher et al., 2010).
The very elderly (≥85 years) is the fastest growing age group in
the world. Most studies of ICH have been carried out on younger
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subjects, and the recent use of novel radiological techniques have
provided extensive information of the condition. We aimed to (1)
investigate the prevalence and risk factors of ICH in the oldest
old in a population-based material, and (2) compare the severity
and topography of microscopic hemorrhagic lesions with other
neuropathologies at the tissue level.
MATERIALS AND METHODS
VANTAA 85+ STUDY PROTOCOL AND PARTICIPANTS
The prospective and population-based Vantaa 85+ Study began
in 1991 and included all individuals aged ≥85 years living in the
city of Vantaa in Southern Finland on April 1, 1991. The clini-
cal follow-up studies were carried out in 1994, 1996, 1999, and
2001. Of all the 601 eligible subjects 553 participated in the clini-
cal study. Post-mortem examinations were performed on 306/553
(55.3%). Of these, two had denied to participate in the clinical
study and four were excluded because of insufﬁcient clinical data.
The present study is based on these 300 subjects (52, 17.3%)males,
with mean age at death 92.4± 3.7 years (males 92.1± 3.6 years).
Table 1 shows the characteristics of the autopsied and clinically
investigated populations.
CLINICAL EXAMINATION
The participants were interviewed by a trained nurse, conducted
using a structured questionnaire consisting of questions con-
cerning health, health-related behavior, and medication. Clinical
examination included general physical examination and neuro-
logical examination by a neurologist. The diagnosis of dementia
was based on the criteria provided by the Diagnostic and Statisti-
cal Manual of Mental Disorders, 3rd edition, revised (DSM III-R;
American Psychiatric Association, 1987), and was based on a con-
sensus diagnosis of two neurologists. Subjects were classiﬁed as
hypertensive if they used any blood pressure lowering medication.
Table 1 | Demographic features of the autopsied subpopulation
compared with the wholeVantaa 85+ study population.
Autopsied, N (%) Clinically
examined, N (%)
300 (54.2) 553 (100)
Age at death (year±SD; range) 92.4±3.7
(85.1−105.6)
92.3±3.8
(85.1–105.7)
Male gender 52 (17.3) 113 (18.8)
Dementia 195 (65.0) 314 (52.2)
Hypertensiona 74 (24.7) 142 (25.8)
Antith/anticob 37 (12.3) 97 (16.1)
APOE ε2-allele carrier 32c (11.5) 79d (13.1)
APOE ε3-allele carrier 269c (89.7) 508d (84.5)
APOE ε4-allele carrier 88c (31.7) 155d (25.8)
SD, standard deviation; Antith/antico, antithrombotic/anticoagulation medication;
APOE, apolipoprotein E.
aDiagnosis based on the use of blood pressure lowering medication.
bASA, warfarin, or dipyramidole.
cAPOE genotyping performed on 278.
dAPOE genotyping performed on 532.
Antithrombotic/anticoagulation medication consisted of acetyl
salicylic acid (ASA), warfarin, or dipyramidole.
AUTOPSY WITH NEUROPATHOLOGICAL EXAMINATION
After the autopsy the brains were ﬁxed in 4% phosphate-buffered
formaldehyde for at least 2 weeks. The presence and extent of
arteriosclerosis of the cerebral blood vessels was analyzed macro-
scopically. The cerebrum was cut in 1 cm thick coronal slices
and the brain stem and cerebellum in approximately 5mm thick
sagittal slices. The presence and location of macroscopic intracere-
bral (deep, DH and lobar, LH) or superﬁcial (subarachnoid, SH)
hemorrhagic lesions was recorded.
MICROSCOPIC ANALYSES
The diagnosis of the microscopic variables was based on the con-
sensus of at least two experienced neuropathologists/pathologists.
Microscopic hemorrhages
We deﬁned the presence of old microscopic brain hemorrhages
(MH) as areas with iron containing macrophages (siderophages)
in the brain tissue. MH was assessed in six brain regions (frontal,
parietal, temporal and occipital lobes, hippocampus and cerebel-
lum). Approximately 25× 20mm wide and 5−6μm thick tissue
slides, containing both cortex and subcortical white matter, were
stained with the histological Prussian blue stain. We counted
the number of cortical and subcortical siderophages and deﬁned
deposits with >5 siderophages in the tissue section as MH+, as a
subgroup of MH. MH and MH+ were used as bivariate variables
and the number of brain regions (0–6) with MH as an ordinal
variable in the statistical analyses. We did not record (1) vascu-
lar iron positivity associated with calcium deposition, observed
as dark blue staining in the H&E stained sections (ferrocalci-
nosis), which was frequently encountered in the cerebellar dentate
nucleus and/or choroid plexus region (Vernooij et al., 2008) or (2)
subcortical purely perivascular iron deposits.
Ischemic lesions
Cortical microinfarctions (MI) were analyzed in the H&E stained
tissue sections in the six brain regions described above. The MI
was deﬁned as a focal lesion ≤1mm2 with neuronal loss, glia cell
and macrophage reaction and/or cystic tissue necrosis, and being
invisible to the naked eye.
Cerebral amyloid angiopathy
The presence of CAA was analyzed in six brain regions (see above)
as previously described (Tanskanen et al., 2012). The diagnosis
of CAA was based on Congo red staining and conﬁrmed using
immunohistochemistry (IHC) against amyloid beta (Aβ) pep-
tide (clone 4G8, detecting amino acids 17→ 24). The severity
of CAA was assessed in two ways. First, the percentage of blood
vessels with CAA was analyzed separately for parenchymal and
leptomeningeal blood vessels in each tissue section of the six brain
regions investigated. The parenchymal and leptomeningeal scores
were combined and the total score for each subject was counted by
adding up the combined scores of the six brain regions and divid-
ing the result by six. Severe CAA was deﬁned as the percentage of
blood vessels with CAA>5.3% (the upper quartile (UQ) value for
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CAA severity in all six brain regions). Cases with the severity value
for CAA ≤5.3% blood vessels with CAA were deﬁned as mild/no
CAA. Secondly, the number of brain regions with CAA (0–6) was
counted.
Microscopic hemorrhage with cerebral amyloid angiopathy
The presence and number of tissue sections showing both MH or
MH+ and CAA was counted. The sections with MH and CAA
were designated as MHCAA and the sections with MH+ and CAA
as MH+CAA. Next, the Prussian blue, Congo red, H&E, and Aβ-
IHC stained tissue sections from samples with MH+/MH+CAA
were analyzed in parallel to investigate the possible co-localization
of siderophages with CAA/MI or larger ischemic lesions. Other
samples, i.e., those with ≤5 sideropahges in the tissue could not be
systematically analyzed this way for two reasons: (1) The Prussian
blue and Congo red stained sections were not always consecutive,
thus the siderophages in Prussian blue stained sections only sel-
dom could be visible in the Congo red stained sections, and (2)
although the siderophages stain brown in Congo red, the pigment
cannot be reliably differentiated from other pigments with Congo
red only.
Alzheimer’s disease-related pathologies
The CERAD scores and Braak stages to investigate the AD-related
neuropathologies were deﬁned as originally described (Braak and
Braak, 1991; Mirra et al., 1991).
GENETIC ANALYSES
APOE genotyping was carried out as previously described (Myl-
lykangas et al., 2002).
STATISTICAL ANALYSES
Statistical analyses were performed using the SPSS (PASW) for
Windows version 20 software. Bivariate logistic regression analysis
was used to predict the presence of ICH,MHCAA, and MH+CAA
(univariate analysis, adjusted for age at death and gender). Corre-
lation between the number of brain regions with MH, MH+, and
CAA was performed using Spearman correlation analysis.
APPROVAL FOR THE STUDY
The Vantaa 85+ study was approved by the Ethics Committee
of the Health Center of the City of Vantaa. The Finnish Health
and Social Ministry approved the use of the health and social
work records and death certiﬁcates. The National Authority for
Medicolegal Affairs (VALVIRA) has approved the collection of
tissue samples at autopsy and allowed their use for research.
Informed consent from the subjects or their relatives was obtained
before the blood samples were collected. For the autopsy a written
consent was obtained from the nearest relatives.
RESULTS
SUBJECTS WITH INTRACEREBRAL HEMORRHAGE
Seven subjects (7/300, 2.3%) had macroscopic ICH. Three (1%)
hadDH, three (1%)LH,andone (0.3%) SH.All three subjectswith
LH had CAA in the microscopic sections were demented and car-
ried the APOE ε4 allele whereas the subjects with SH had none of
these variables. Of those with DH none were hypertensive accord-
ing to the criteria used here. MH in at least one brain region was
found in 186 (186/300, 62%) subjects and MH+ in 16 (5.3%). The
clinical, genetic, and neuropathological data of the subjects with
macroscopic hemorrhage (DH, LH, and SH combined), MH, and
MH+ is shown in Table 2.
MICROSCOPIC INTRACEREBRAL HEMORRHAGE
The majority of the 186 subjects with MH had a single lesion in
one brain region only (Figure 1). Mostly (in 167 subjects, 89.8%),
the lesions consisted of a single siderophage. Three subjects had
2–5 siderophages and 16 (16/186, 8.6%) had deposits with >5
siderophages (MH+) in the tissue. All deposits were cortical or
leptomeningeal.
Similarly to MH, most subjects with MH+ (13/16, 81.2%) had
the lesion in one brain region only (Figure 1). In total therewere 22
MH+ lesions in the 16 subjects. The MH+ deposits were invari-
ably >2mm wide. The largest deposits were up to 10mm wide
and included superﬁcial cortical layers with the above-situated
leptomeningeal tissue involved. Subjects with MH+ frequently
had cortical MI (Table 2). 12 of the 22 tissue sections (54.5%)
with MH+ also contained an infarct, either cortical MI (4) or a
larger lesion. TheseMH+ lesionswere always co-localizedwith the
infarct except in two cases. MH and MH+ were most prevalent in
the parietal lobe (Figure 2).
CORRELATION ANALYSES
Correlation analyses showed (1) lack of correlation between the
presence of MH/MH+ and the presence of CAA, (2) lack of cor-
relation between the number of brain regions with MH and the
number of brain regions with CAA, and (3) the presence of MH+
correlated with the number of brain regions with CAA (Spearman
correlation coefﬁcient 0.129, p = 0.026).
MICROSCOPIC INTRACEREBRAL HEMORRHAGE WITH CEREBRAL
AMYLOID ANGIOPATHY
One hundered four subjects (104/300, 34.7%) had MH and CAA
in the same tissue section (MHCAA). Of those 16 subjects with
MH+, 13 (13/16, 81.2%) had CAA in the same tissue section
(MH+CAA). Table 3 shows the characteristics of subjects with
MHCAA and MH+CAA. Similarly to MH, most subjects with
MHCAA (58/104, 55.8%) had the lesion in one cerebral region
only (Figure 1), most frequently in the parietal lobe (Figure 3).
Of the 13 subjects withMH+CAA,10 (76.9%) had the lesion in
a single brain region (Figure 1), altogether 17 lesions were found.
These lesions were most frequent in the parietal lobe, similarly
to MH, MH+, and MHCAA (Figure 3). Microscopic analysis of
the Prussian blue, H&E, Congo red and Aβ-IHC-stained tissue
sections of the 17 samples with MH+CAA revealed that (1) the
width of the area with siderophages roughly correlated with the
extent of CAA and (2) the siderophages were located close to CAA-
vessels, either cortically or leptomeningeally, or both. This became
especially clear in the samples with mild CAA, whereas in the
samples with severe CAA the number of macrophages close to
the CAA blood vessels varied. (3) In most samples (12/17, 70.6%)
with MH+CAA the severity of CAA was high (median severity of
CAA>5.3%). This becomes even more obvious when the median
severity value of CAA in the 17 samples from the 13 subjects with
MH+CAA (25%)was comparedwith themedian severity value of
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Table 2 | Characteristics of subjects with macroscopic and microscopic cerebral hemorrhages.
Variable Macroscopic hemorrhagea,b MHb MH+ Total OR (p-value)c MH+ vs. MH−
N (%) 7 (2.3) 186 (62.0) 16 (5.3) 300 (100)
Age (years±SD) 91.5±1.7 92.4±3.7 92.7±4.6 92.4±3.7 NS
Male gender 0 (0) 33 (17.7) 5 (31.2) 52 (17.3) NS
Dementia 4 (57.1) 116 (62.4) 10 (62.5) 195 (65.0) NS
Hypertensiond 0 (0) 43 (23.2) 5 (31.2) 74 (24.7) NS
Antith/anticoe 1 (14.3)f 26 (14.0) 0 (0) 37 (12.3) NS
APOE ε2-allele+g 1 (14.3) 19 (10.7) 4 (25.0) 32 (11.5) NS
APOE ε3-allele+g 7 (100) 171 (96.6) 14 (87.5) 269 (89.7) NS
APOE ε4-allele+g 3 (42.9) 54 (30.5) 10 (62.5) 88 (31.7) 3.681 (0.017)
Ath 4 (57.1) 117 (68.0) 12 (80.0) 280 (93.3) NS
Braak stages 5–6 1 (14.3) 44 (23.7) 5 (31.2) 72 (24.0) NS
CERAD C 1 (14.3) 26 (14.0) 2 (12.5) 39 (13) NS
CAA+h 5 (71.4) 123 (66.1) 12 (75.0) 209 (69.7) NS
Cortical MIh 1 (14.3) 60 (32.3) 9 (56.2) 96 (32.0) 2.948 (0.040)
MH,microscopic brain hemorrhage;MH+,MHwith> 5 pigmentedmacrophages;OR,Odd’s ratio; SD, standard deviation;Antith/antico, antithrombotic/anticoagulation
medication; APOE, apolipoprotein E; Ath, atherosclerosis of the cerebral arteries; CAA, cerebral amyloid angiopathy; MI, micro infarction.
aCombined counts for the deep, lobar, and subarachnoidal hemorrhages (DH, LH, SH).
bResults of the association analyses between macroscopic hemorrhages/MH and the clinical variables NS.
cLogistic regression analysis, adjusted for age at death and gender.
dDiagnosis based on the use of blood pressure lowering medication.
eASA in 25, warfarin in 11, dipyridamidole in 11 patients.
fASA.
gAPOE genotyping performed in 278 subjects.
hFocal lesion ≤1mm2 with neuronal loss, glia cell and macrophage reaction and/or cystic tissue necrosis, invisible to the naked eye, analyzed in six brain regions.
FIGURE 1 | Number of brain regions with microscopic hemorrhage
(MH) or MH+ (lesion with >5 siderophages) and of brain regions with
concomitant cerebral amyloid angiopathy (CAA) and MH (MHCAA,
MH+CAA).
the whole study population (1.0%, Tanskanen et al., 2012). Sim-
ilarly to MH+, the siderophages in MH+CAA also co-localized
with the infarct (Figure 4). (4) The tissue sections from the sub-
jects with MH+CAA showed a high number of infarcts (either
MI or larger). Altogether 9 infarcts were found, 4 of which were
MI. When the hemorrhagic lesion was associated with MI, a small
FIGURE 2 |The distribution of the cerebral microhemorrhages (MH)
and the lesions with >5 siderophages (MH+).
artery was often found in the center/near the center of the lesion,
but when in association with larger infarcts it was not possible to
show which vessel had bled.
DISCUSSION
MACROSCOPIC INTRACEREBRAL HEMORRHAGE
The prevalence of macroscopic ICH (of any type, Table 2)
was low (2.3%) when compared with a previous population-
based British autopsy study (demented 6%, non-demented 3%;
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Table 3 | Characteristics of subjects with microscopic brain
hemorrhage (MH, MH+) concomitantly with CAA in the same brain
region (MHCAA, MH+CAA).
Variable MHCAA OR
(p-value)a
MH+CAA OR
(p-value)a
N (%) 104 (55.9) 13 (81.2)
Age (years±SD)b 92.4±3.7 NS 93.1±5.1 NS
Male genderc 23 (22.1) NS 5 (38.5) 3.267
(0.045)
Dementia 70 (67.3) NS 9 (69.2) NS
Hypertensiond 22 (21.4) NS 3 (23.1) NS
Antith/anticoe 12 (11.5) NS 0 (0) NS
APOE ε2-allele+f 10 (10.1) NS 3 (23.1) NS
APOE ε3-allele+f 95 (96.0) NS 11 (84.6) 0.159
(0.040)g
APOE ε4-allele+f 49 (49.5) 3.291
(<0.001)
10 (76.9) 7.522
(0.003)
Ath 92 (93.9) NS 9 (75.0) NS
Braak stages 5–6 35 (33.7) 2.294
(0.003)
4 (30.8) NS
CERAD C 21 (20.2) 2.445
(0.011)
2 (15.4) NS
Cortical MIh 41 (39.8) NS 7 (53.8) NS
CAA, cerebral amyloid angiopathy; MH, microscopic hemorrhage; MH+, micro-
scopic hemorrhage with >5 pigmented macrophages; OR, Odd’s ratio; SD, stan-
dard deviation; Antith/antico, antithrombotic/anticoagulation medication; APOE,
apolipoprotein E; Ath, atherosclerosis of the cerebral arteries; MI, microinfarc-
tion.
aAdjusted for age at death and gender.
bAdjusted for gender.
cAdjusted for age at death.
dDiagnosis based on the use of blood pressure lowering medication.
eASA in 25, warfarin in 11, dipyridamidole in 11 patients.
fAPOE genotyping performed in 278.
gB= −1.838 (negative correlation).
hFocal lesion ≤1mm2 with neuronal loss, glia cell and macrophage reaction and/or
cystic tissue necrosis, invisible to the naked eye, analyzed in six brain regions.
Neuropathology Group, Medical Research Council Cognitive
Function and Aging Study, 2001). The prevalence of DH was
low (1%) and the prevalence of LH high (1%) when compared
with the prevalence counts in younger subjects (Lavados et al.,
2010). The APOE ε4 allele was common in LH, similarly to a
previous study (Bifﬁ et al., 2010). We did not detect an over-
representation of APOE ε2-allele, not even in the subjects with
LH that would have been expected based on previous investi-
gations (McCarron and Nicoll, 1998). The likely reason for this
seems to be (1) the considerably high mean age and (2) low preva-
lence of APOE ε2-allele in the study population (Table 1). Two of
the three subjects with DH had both arteriosclerotic changes in
the cerebral blood vessels and the APOE ε4 allele, the established
risk factor for atherosclerosis (Mahley and Rall, 2000), whereas
none had hypertension. Because of the low number of subjects
with DH and how the diagnosis of hypertension was obtained,
the present study does not allow further conclusions regarding
FIGURE 3 |The distribution of the MH (cerebral microhemorrhages)
and MH+ (lesions with >5 siderophages) with CAA concomitantly in
the same brain region (MHCAA, MH+CAA).
the risk of ICH in hypertensive elderly patients. Similarly, the
number of subjects using antithrombotic/anticoagulation med-
ication was relatively small. Interestingly, every subject with LH
was demented, which is in contrast with the younger patients who
mostly are non-demented before the ﬁrst bleed (Mandybur, 1986).
Putative explanations include (1) the carriership of the APOE ε4
allele (all three patients) and (2) atherosclerosis of the cerebral
arteries (present in two of the three patients). This is supported by
ﬁndings that both of these variables are associated with dementia
(Mortimer et al., 2009).
MICROSCOPIC INTRACEREBRAL HEMORRHAGE
MH was frequent and not associated with any of the clinical,
genetic or neuropathological variables investigated (Table 2).
Although more than half of the subjects with MH had concomi-
tant CAA in the same brain region (Table 3), MH and CAA were
not correlated. MH was cortical/leptomeningeal, in agreement
with a previous histological study of patients with neurodegener-
ative dementia showing mainly cortical deposits (De Reuck et al.,
2011).
The frequency of MH+, in contrast, was very low (16/300,
5.3%)when comparedwith the frequency in the population-based
MRI studies of younger patients (15.3 and 11.1% (Sveinbjornsdot-
tir et al., 2008; Poels et al., 2010). The obvious reason lies in the
methodological differences. The whole brain tissue cannot be ana-
lyzed in the microscope, whereas the MRI scan detects large brain
areas at a glance−apparent advantage of the method.
The subjects with MH+ over expressed the APOE ε4 allele
(Table 2), as has been previously shown in subjects with microb-
leeds (Sveinbjornsdottir et al., 2008; Vernooij et al., 2008; Poels
et al., 2011).
MICROSCOPIC INTRACEREBRAL HEMORRHAGE WITH CEREBRAL
AMYLOID ANGIOPATHY
MH+ was invariably close to CAA in the tissue sections (although
not necessarily vice versa), and so our results are in agreement
www.frontiersin.org June 2012 | Volume 3 | Article 103 | 5
Tanskanen et al. Intracerebral hemorrhage in the aged
FIGURE 4 | Siderophages (arrow head) close to a small blood vessel with
CAA (arrow) in the frontal cortex with subacute infarction. (A) Prussian
blue, (B) H&E, (C) Congo red, (D) immunohistochemistry against amyloid
beta (Aβ) peptide. Original magniﬁcation ×200. Scale bar 100μm.
with a previous study (Schrag et al., 2010) which showed Aβ
protein in the ruptured blood vessels in the histological samples
of microbleeds. Moreover, the severity of CAA in the samples
with MH+CAA was clearly higher than the severity of CAA in
the whole population. This ﬁnding conﬁrms previously published
data (Greenberg and Vonsattel, 1997), suggesting that severe CAA
would be a pre-requisite for bleeding in CAA. It is clear that CAA
and MH differ from each other signiﬁcantly in the terms of the
width of distribution. CAA is wide-ranging (Tanskanen et al.,
2012) whereas MH is preferentially local (Figure 1), and not all
CAA-lesions, although they would be severe, do bleed. Therefore,
a question is raised, that if there are other causes for MH in the
subjects with CAA.
Subjects with MH+ had an unexpectedly high number of MI
anywhere in the brains (Table 2). The proportion of subjects with
MI in those with MH+CAA was also high (Table 3) when com-
pared with those with MHCAA (Table 3). The difference however
was not statistically signiﬁcant,– probably due to the small number
of subjects with MH+CAA. However, microscopic examination
showed that most of the tissue samples with both MH+ (12/22)
and MH+CAA (9/17) associated with an infarct (Figure 4) –
either MI or larger in the histological sections. Furthermore, the
siderophages (>5) in MH+ and MH+CAA nearly always co-
localized with the infarction. Thus, it seems that the hemorrhagic
transformation in the infarction may be an important cause for
MH+ in the very elderly. A previous study indeed showed that
ischemic stroke predisposes to new microbleeds (Gregoire et al.,
2010).
Theover-representationof theAPOE ε4 allelewas even stronger
in the subjects with MHCAA (Table 3) and especially strong in the
subjects with MH+CAA (Table 3). APOE ε4 is also a risk factor
for CAA, and therefore the association between MH and APOE ε4
may just be the consequenceof CAA in these subjects. Interestingly,
MHCAA was weakly associated with AD-pathology (Braak stages
5−6 and CERAD score C) whereas MH+CAA was not, probably
due to the small number of subjects with MH+CAA. MH+CAA
associated weakly with male gender, conceivably due to the higher
prevalence of CAA in males in our study population (Tanskanen
et al., 2012).
MRI AND HISTOPATHOLOGY CORRELATIONS
Even though our study did not include imaging techniques, it is
intriguing to speculate about the histopathological counterparts
of the radiologically detected microbleeds, especially (1) which is
the role of CAA,and (2) are theMIs involved?We found thatMH+
(but not MH) associated with APOE ε4, similarly to the microb-
leeds. However, this was true for MH+CAA and MHCAA as well.
It has also been suggested that there is a topographic association
between the radiologically detected microbleeds and CAA (Dierk-
sen et al., 2010), especially in the subjects with AD (Nakata-Kudo
et al., 2006), similarly to what was discovered in LH (Greenberg
et al., 2004; Ly et al., 2010), referring to the involvement of CAA
in the microbleeds. Here the prevalence of MH+CAA was high-
est in the parietal lobe (Figure 3), consistent with the microbleeds
(Sveinbjornsdottir et al., 2008; Poels et al., 2011).However, parietal
lobe was the predilection site for all other types of lesions (MH,
MH+,MHCAA) aswell (Figures 2 and 3). The spatial distribution
of the lesions as such neither supports nor contrasts the sugges-
tion. Indeed, the high frequency of MHCAA and MH+CAA in the
parietal lobe may be due to CAA because the prevalence of CAA in
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the present population was highest in the parietal lobe (Tanskanen
et al., 2012).
CONCLUSION
Macroscopic ICH was rare in the very elderly. MH was a fre-
quent and innocent lesion. MH+ in contrast was rare and closely
related with the APOE ε4 genotype, the presence of severe CAA
and infarction. Further investigations aimed at directly comparing
the MRI results with neuropathological data would be of interest.
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